A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

Children’s Hospital of Orange County Orange, California, United States, 92868 Contact: Heather Speer    714-509-8613    HSpeer@choc.org    Principal Investigator: Mark Daniels, MD          University of California – San Francisco San Francisco, California, United States, 94143 Contact: Rebecca Wesch    415-476-5984    rebecca.wesch@ucsf.edu    Contact: Karen Ko    415-514-3730    karen.ko@ucsf.edu    Principal Investigator: Stephen Gitelman, MD          Stanford University Stanford, California, United States, 94305 Contact: Trudy Esrey    650-498-4450    tesrey@stanford.edu    Principal Investigator: Darrell Wilson, MD          Barbara Davis Center at University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 Contact: Morgan Sooy    303-724-5686    MORGAN.QUIST@CUANSCHUTZ.EDU    Principal Investigator: Andrea Steck, MD          Yale University School of Medicine New Haven, Connecticut, United States, 06519 Contact: Laurie Feldman    203-737-2760    laurie.feldman@yale.edu    Principal Investigator: Kevan Herold, MD, Ph.D.          University of Florida Gainesville, Florida, United States, 32610 Contact: Jennifer Hosford    352-294-5759    jennifer.hosford@peds.ufl.edu    Principal Investigator: Michael Haller, MD          Emory Children’s Center Atlanta, Georgia, United States, 30329 Contact: Xiaomiao Lan-Pidhainy    404-712-0051    xlanpid@emory.edu    Principal Investigator: Andrew Muir, MD          Indiana University – Riley Hospital for Children Indianapolis, Indiana, United States, 46202 Contact: Maria Spall    317-278-8879    malnicho@iu.edu    Principal Investigator: Linda DiMeglio, MD          Joslin Diabetes Center Boston, Massachusetts, United States, 02215 Contact: Jason Gaglia, MD    888-813-8669    TrialNet@joslin.harvard.edu    Principal Investigator: Jason Gaglia, MD          Regents of the University of Minnesota Minneapolis, Minnesota, United States, 55466 Contact: Janice Leschyshyn    612-626-8467    lesch004@umn.edu    Principal Investigator: Antoinette Moran, MD          The Children’s Mercy Hospital Kansas City, Missouri, United States, 64108 Contact: Jennifer James    913-696-5059    jljames@cmh.edu    Principal Investigator: Wayne Moore, MD          The Naomi Berrie Diabetes Center at Columbia University Medical Center New York, New York, United States, 10032 Contact: Sarah Pollak    212-851-5425    sjp2174@columbia.edu    Principal Investigator: Robin Goland, MD          University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 Contact: Kelli DeLallo    412-692-5210    kelli.delallo@chp.edu    Principal Investigator: Dorothy Becker, MD          Vanderbilt Eskind Diabetes Center Nashville, Tennessee, United States, 37232 Contact: Faith Brendle    615-936-8638    faith.brendle@vumc.org    Principal Investigator: William Russell, MD          University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Contact: Serey Sao    214-648-3061    serey.sao@utsouthwestern.edu    Contact: Lindsay Harter       Lindsay.Harter@UTSouthwestern.edu    Principal Investigator: Perrin White, MD          Benaroya Research Institute Seattle, Washington, United States, 98101 Contact: Corinna Tordillos    206-341-8937    ctordillos@benaroyaresearch.org    Principal Investigator: Carla Greenbaum, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.